Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
Journal for Immunotherapy of Cancer|January 22, 2026
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgeryStephen Boulton, Siddharth Singh, Bailey Organ, et al.Nature Biotechnology|January 28, 2014
Smac mimetics and innate immune stimuli synergize to promote tumor deathShawn T Beug, Vera A Tang, Eric C LaCasse, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.Journal of Cancer Research and Clinical Oncology|February 8, 2021
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlationBrian A Keller, Brian J Laight, Oliver Varette, et al.Cancer Research|October 24, 2012
Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cellsLee-Hwa Tai, Christiano Tanese de Souza, Simon Bélanger, et al.Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.Oncoimmunology|February 6, 2018
Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cellsTiphaine Delaunay, Mathilde Violland, Nicolas Boisgerault, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Targeting tumor vasculature with an oncolytic virusCaroline J Breitbach, Naomi S De Silva, Theresa J Falls, et al.Cancer Immunology Research|February 5, 2017
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular VaccineAlmohanad A Alkayyal, Lee-Hwa Tai, Michael A Kennedy, et al.Pageof 20